V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320007277 | 320003887 | 1.66 | 77.1 | Palliative (P) | 2014-01-04 | 2014-05-17 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | Y | 320020709 | CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 320007278 | 320003896 | 1.51 | 78 | Palliative (P) | null | 2015-12-22 | PAC-PLAT | N | N | 320020795 | PEMBROLIZUMAB |
| 320007280 | 320003908 | 1.88 | 141.7 | Palliative (P) | 2015-05-07 | 2015-06-11 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | N | 320021011 | PEMBROLIZUMAB |
| 320007281 | 320003920 | 1.56 | 72.4 | Palliative (P) | 2014-12-03 | 2015-02-16 | Ipilimumab | N | N | 320022758 | BCG |
| 320007282 | 320003923 | 1.46 | 96.5 | Disease modification (D) | 2017-12-04 | 2017-12-12 | PEMBROLIZUMAB | 02 | N | 320022776 | CETUXIMAB + RT |
| 320007283 | 320003928 | 1.78 | 86.2 | Not known (9) | null | 2019-08-30 | IVA | N | N | 320022811 | GEMCITABINE |
| 320007284 | 320003930 | 1.7 | 64.5 | Adjuvant (A) | 2018-10-01 | 2018-10-01 | Bevacizumab+Carbo+Pacliaxel | 02 | N | 320022821 | CAPECITABINE + OXALIPLATIN |
| 320007285 | 320003940 | 1.66 | 53 | null | 2014-06-03 | 2016-04-01 | CETUXIMAB + RT | 02 | N | 320022881 | MVAC |
| 320007286 | 320005803 | 1.48 | null | Disease modification (D) | 2018-08-25 | 2018-11-19 | Carboplatin + Pemetrexed | null | null | 320022903 | CAPECITABINE + TEMOZOLOMIDE |
| 320007287 | 320003960 | 0 | 76.4 | Palliative (P) | 2016-01-09 | 2016-01-13 | TEMOZOLOMIDE | N | Y | 320023133 | CARBOPLATIN + ETOPOSIDE |
| 320007288 | 320005816 | 1.76 | 53 | Palliative (P) | 2015-06-11 | 2015-06-12 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 320023143 | DOCETAXEL |
| 320007289 | 320003969 | 1.66 | 101 | Adjuvant (A) | 2018-07-20 | 2018-08-11 | Cisplatin + Docetaxel +Fluorouracil | N | N | 320023192 | PEMETREXED |
| 320007290 | 320003980 | 1.63 | 70.1 | Palliative (P) | 2016-12-27 | 2016-12-30 | Docetaxel 75mg/m2 (21 day) | N | N | 320023276 | ETOPOSIDE |
| 320007291 | 320003991 | 1.71 | 57 | Adjuvant (A) | 2016-11-20 | 2016-12-24 | Trabectedin | N | N | 320023393 | ECX |
| 320007292 | 320007474 | null | 100 | Curative (C) | 2015-07-08 | 2015-11-10 | TCF | null | null | 320023465 | TEMOZOLOMIDE |
| 320007293 | 320004006 | 1.62 | 94 | Palliative (P) | 2018-08-21 | 2018-10-11 | PEMBROLIZUMAB | N | N | 320023538 | CISPLATIN + GEMCITABINE |
| 320007294 | 320005838 | 1.59 | 80.35 | Palliative (P) | 2016-03-24 | 2018-08-30 | CARBOPLATIN + METHOTREXATE + VINBLASTINE | 02 | Y | 320023546 | OLAPARIB |
| 320007295 | 320004030 | 1.64 | 94.7 | Palliative (P) | 2018-12-06 | 2019-01-12 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 320023709 | NIRAPARIB |
| 320007296 | 320005849 | 1.76 | null | Palliative (P) | 2014-10-03 | 2015-08-27 | Carbo F | 02 | N | 320023794 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 320007297 | 320004041 | 1.75 | 76.4 | Palliative (P) | 2018-06-04 | 2018-06-04 | Etoposide oral | 2 | N | 320023838 | ETOPOSIDE + IFOSFAMIDE |
| 320007298 | 320004050 | 1.7 | 81.9 | Disease modification (D) | 2018-03-27 | 2018-05-23 | BCG Intravesical | null | null | 320023912 | IMATINIB |
| 320007299 | 320004054 | 1.58 | 72 | Palliative (P) | 2018-03-04 | 2018-03-07 | Cisplatin + Vinorelbine (IV) | N | N | 320023924 | RITUXIMAB |
| 320007300 | 320004056 | 1.53 | 73.6 | Palliative (P) | 2016-06-17 | 2016-09-17 | Atezolizumab | N | N | 320023942 | CETUXIMAB + RT |
| 320007301 | 320004059 | 1.81 | 133 | Palliative (P) | 2017-02-18 | 2017-03-05 | ICON8 TRIAL | 02 | null | 320023958 | NIRAPARIB |
| 320007302 | 320004071 | 1.57 | 60.5 | Palliative (P) | 2014-07-11 | 2015-07-09 | CARBOPLATIN + ETOPOSIDE | Y | N | 320024027 | CARBOPLATIN + RT |
| 320007303 | 320004088 | 1.71 | 15 | Adjuvant (A) | null | 2017-01-21 | Doxorubicin + Ifosfamide | null | N | 320025218 | CETUXIMAB + CISPLATIN + FU |
| 320007304 | 320004096 | 1.6 | 81.9 | Palliative (P) | 2019-04-12 | 2019-04-12 | Enzalutamide | 2 | N | 320002615 | PEMBROLIZUMAB |
| 320007305 | 320004109 | 1.68 | 66.9 | Palliative (P) | 2017-05-26 | 2017-06-04 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 320004866 | IPILIMUMAB |
| 320007306 | 320004123 | null | 74 | Palliative (P) | 2018-02-06 | 2018-03-03 | POUT TRIAL | N | N | 320007896 | BENDAMUSTINE + RITUXIMAB |
| 320007307 | 320007126 | 1.78 | 57.2 | Palliative (P) | 2016-05-12 | 2016-05-13 | ECX | N | N | 320008313 | DOCETAXEL |
| 320007308 | 320007316 | 1.65 | 79.9 | Palliative (P) | 2019-01-31 | 2019-02-04 | CARBOPLATIN + RT | 2 | N | 320008744 | TEMOZOLOMIDE |
| 320007309 | 320004156 | null | 57 | Curative (C) | 2018-11-05 | 2018-11-13 | Topotecan (intravenous) | N | N | 320009487 | CAPECITABINE + OXALIPLATIN |
| 320007310 | 320004159 | 1.7 | null | Palliative (P) | 2014-12-10 | 2017-02-02 | PEMBROLIZUMAB | 2 | Y | 320009502 | NIVOLUMAB |
| 320007311 | 320004168 | 1.63 | null | Palliative (P) | null | 2016-08-18 | ECarboF | null | null | 320011028 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 320007312 | 320004184 | null | 81.9 | Palliative (P) | 2019-01-27 | 2019-01-29 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | null | 320012197 | REGORAFENIB |
| 320007313 | 320007402 | 1.55 | 83 | Palliative (P) | 2019-02-13 | 2019-05-16 | CAPECITABINE + OXALIPLATIN | N | N | 320014151 | RMS 2005 TRIAL |
| 320007314 | 320005934 | 1.7 | 55.3 | Adjuvant (A) | 2016-09-30 | 2016-10-04 | ICON8B TRIAL | N | N | 320018048 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 320007315 | 320004229 | 1.78 | 37.55 | Palliative (P) | 2015-04-18 | 2016-05-07 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 320019034 | CARBO + FLUOROURACIL |
| 320007316 | 320004240 | 1.75 | 71 | Palliative (P) | 2015-05-09 | 2017-01-07 | CARBOPLATIN + CETUXIMAB + FU | 2 | N | 320020239 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 320007317 | 320005947 | 1.7 | 62.8 | Curative (C) | 2018-03-08 | 2018-03-29 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 01 | N | 320021324 | ICON TRIAL |
| 320007318 | 320004275 | 1.63 | 73.8 | Palliative (P) | 2016-11-07 | 2017-01-27 | Pertuzumab | 02 | N | 320021893 | SUNITINIB |
| 320007319 | 320004277 | 1.84 | 69.3 | Palliative (P) | 2018-05-06 | 2018-05-11 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 320022034 | NIVOLUMAB |
| 320007320 | 320004280 | 1.8 | null | null | 2017-10-04 | 2017-10-20 | CNS LGG 2004 03 vinc weekly+ carbo | N | null | 320022352 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320007321 | 320004302 | 1.71 | 57.4 | Adjuvant (A) | 2019-07-18 | 2019-07-19 | Niraparib | 02 | N | 320008329 | NIRAPARIB |
| 320007322 | 320004305 | 1.67 | 61.6 | Palliative (P) | 2017-11-25 | 2019-01-03 | ICON8 TRIAL | 2 | N | 320008581 | MITOXANTRONE |
| 320007323 | 320005978 | 1.84 | 62.7 | Palliative (P) | 2016-12-22 | 2017-04-20 | CARBOPLATIN + RT | 02 | N | 320009033 | TEMOZOLOMIDE |
| 320007324 | 320004313 | 1.76 | 81.9 | null | null | 2019-01-15 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 320010225 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320007325 | 320004326 | 1.56 | 51.7 | Palliative (P) | 2017-10-16 | 2018-03-08 | Bevacizumab + CARBOPLATIN + PACLITAXEL | Y | N | 320021501 | OCTOPUS TRIAL |
| 320007326 | 320002685 | 1.62 | 52.7 | Palliative (P) | 2015-07-08 | 2015-07-09 | CARBOPLATIN | N | N | 320001353 | CARBOPLATIN |
| 320007327 | 320002699 | 1.9 | 60 | Palliative (P) | 2014-02-10 | 2014-02-19 | Paclitaxel 7 day | 2 | N | 320002703 | PACLITAXEL |